Recently, ultrasound imaging has been used to measure disease progress directly in vivo for various neuromuscular disorders, including SMA and DMD, by measuring tissue echogenicity (brightness) or increased fibrosis [9-14]. Here, SMN1 is linked to Duchenne muscular dystrophy.